Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maarten Postma

Showing results (31-40 of 98) with videos related to

Pageof 10
Sort By:
Plos One|April 13, 2011
Modelling the costs and effects of selective and universal hospital admission screening for methicillin-resistant Staphylococcus aureusGijs Hubben, Martin Bootsma, Michiel Luteijn, et al.
Plos One|November 28, 2019
The implementation of HTA in medicine pricing and reimbursement policies in Indonesia: Insights from multiple stakeholdersRiswandy Wasir, Sylvi Irawati, Amr Makady, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 17, 2015
Which factors enhance positive drug reimbursement recommendation in Scotland? A retrospective analysis 2006-2013Mata Charokopou, Istvan M Majer, Johan de Raad, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 25, 2024
A cost-minimization analysis of anti-VEGFs for the treatment of neovascular age-related macular degeneration in the NetherlandsSara W Quist, Hidde Nab, Maarten Postma, et al.
American Journal of Respiratory and Critical Care Medicine|December 15, 2010
Costs and consequences of additional chest x-ray in a tuberculosis prevention program in BotswanaTaraz Samandari, David Bishai, Michiel Luteijn, et al.
Antibiotics (Basel, Switzerland)|July 29, 2025
Do We Need Meropenem Treatment Beyond 7 Days in Febrile Neutropenic Patients: A Cost-Effectiveness AnalysisLeyla Yumrukaya, Arnold Hagens, Ahmet Çağkan İnkaya, et al.
Frontiers in Medical Technology|February 14, 2022
Reconstructing the Effectiveness of Policy Measures to Avoid Next-Wave COVID-19 Infections and Deaths Using a Dynamic Simulation Model: Implications for Health Technology AssessmentArnold Hagens, Kathya Cordova-Pozo, Maarten Postma, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|September 20, 2012
Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-5Richard Pitman, David Fisman, Gregory S Zaric, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 25, 2012
Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--5Richard Pitman, David Fisman, Gregory S Zaric, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 13, 2022
Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in The NetherlandsRimma Velikanova, Simon van der Schans, Matthias Bischof, et al.
Pageof 10

Showing results (31-40 of 98) with videos related to

Sort By:
Pageof 10
Plos One|April 13, 2011
Modelling the costs and effects of selective and universal hospital admission screening for methicillin-resistant Staphylococcus aureusGijs Hubben, Martin Bootsma, Michiel Luteijn, et al.
Plos One|November 28, 2019
The implementation of HTA in medicine pricing and reimbursement policies in Indonesia: Insights from multiple stakeholdersRiswandy Wasir, Sylvi Irawati, Amr Makady, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 17, 2015
Which factors enhance positive drug reimbursement recommendation in Scotland? A retrospective analysis 2006-2013Mata Charokopou, Istvan M Majer, Johan de Raad, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 25, 2024
A cost-minimization analysis of anti-VEGFs for the treatment of neovascular age-related macular degeneration in the NetherlandsSara W Quist, Hidde Nab, Maarten Postma, et al.
American Journal of Respiratory and Critical Care Medicine|December 15, 2010
Costs and consequences of additional chest x-ray in a tuberculosis prevention program in BotswanaTaraz Samandari, David Bishai, Michiel Luteijn, et al.
Antibiotics (Basel, Switzerland)|July 29, 2025
Do We Need Meropenem Treatment Beyond 7 Days in Febrile Neutropenic Patients: A Cost-Effectiveness AnalysisLeyla Yumrukaya, Arnold Hagens, Ahmet Çağkan İnkaya, et al.
Frontiers in Medical Technology|February 14, 2022
Reconstructing the Effectiveness of Policy Measures to Avoid Next-Wave COVID-19 Infections and Deaths Using a Dynamic Simulation Model: Implications for Health Technology AssessmentArnold Hagens, Kathya Cordova-Pozo, Maarten Postma, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|September 20, 2012
Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-5Richard Pitman, David Fisman, Gregory S Zaric, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 25, 2012
Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--5Richard Pitman, David Fisman, Gregory S Zaric, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 13, 2022
Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in The NetherlandsRimma Velikanova, Simon van der Schans, Matthias Bischof, et al.
Pageof 10